A new simple and rapid dual assay for AFP and free β hCG in screening for Down syndrome
- 1 January 1994
- journal article
- research article
- Published by Wiley in Clinical Genetics
- Vol. 45 (1) , 1-4
- https://doi.org/10.1111/j.1399-0004.1994.tb03980.x
Abstract
We have evaluated a simple and rapid 2-step dual-label assay (DELFIA) for alphafetoprotein (AFP) and free beta subunit of human gonadotropin (hCG beta) in second-trimester screening for Down syndrome. Based on stored serum samples from 1059 normal control pregnancies and 72 cases of Down syndrome, we have found the mean Multiple of Median (MoM) for AFP and free hCG beta to be 0.70 and 2.31, respectively. This is slightly but not significantly better than the values for the separate assay for AFP (0.76 MoM) and for intact hCG (2.11 MoM). However, the dual assay is much simpler than the separate assays and therefore prospective comparison trials should be carried out.Keywords
This publication has 13 references indexed in Scilit:
- Simultaneous assay of alpha-fetoprotein and free beta subunit of human chorionic gonadotropin by dual-label time-resolved immunofluorometric assayClinical Chemistry, 1993
- The use of free β‐hCG in antenatal screening for Down's syndromeBJOG: An International Journal of Obstetrics and Gynaecology, 1993
- Free Beta Human Choriogonadotropin in Down's Syndrome Screening: A Multicentre Study of its Role Compared with other Biochemical MarkersAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1992
- Prenatal Screening for Down's Syndrome with Use of Maternal Serum MarkersNew England Journal of Medicine, 1992
- Dual Analyte Immunoassay—a New Approach to Neural Tube Defect and Down's Syndrome ScreeningAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1992
- Early Detection of Down's Syndrome Using Free Beta Human ChoriogonadotropinAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1992
- Improved performance in a prenatal screening programme for Down's syndrome incorporating serum‐free hCG subunit analysesPrenatal Diagnosis, 1992
- Maternal serum Down syndrome screening: Free β-protein is a more effective marker than human chorionic gonadotropinAmerican Journal of Obstetrics and Gynecology, 1990
- Maternal serum markers in screening for Down syndromeClinical Genetics, 1990
- Maternal serum screening for Down's syndrome in early pregnancy.BMJ, 1988